{"product_id":"rheumatoid-arthritis-clinic-running-expenses","title":"What Are Operating Costs For Rheumatoid Arthritis Treatment Clinic?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eRheumatoid Arthritis Treatment Clinic Running Costs\u003c\/h2\u003e\n\u003cp\u003eExpect initial monthly running costs for a Rheumatoid Arthritis Treatment Clinic to range between \u003cstrong\u003e$115,000 and $130,000\u003c\/strong\u003e in 2026, driven by high fixed payroll and specialty drug inventory This guide breaks down the seven critical operating expenses, from the $12,000 facility lease to the 85% cost of specialty biologics, ensuring you budget for the required $846,000 minimum cash buffer needed by February 2026\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 Operational Expenses to Run \u003c\/span\u003eRheumatoid Arthritis Treatment Clinic\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eOperating Expense\u003c\/th\u003e\n\u003cth\u003eExpense Category\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003eMin Monthly Amount\u003c\/th\u003e\n\u003cth\u003eMax Monthly Amount\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eFixed Admin Payroll\u003c\/td\u003e\n\u003ctd\u003eFixed Overhead\u003c\/td\u003e\n\u003ctd\u003eFixed payroll for leadership and administrative staff totals approximately $51,667 per month.\u003c\/td\u003e\n\u003ctd\u003e$51,667\u003c\/td\u003e\n\u003ctd\u003e$51,667\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eBiologic Drug Inventory\u003c\/td\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003eThis is the largest COGS component, projected at 85% of revenue in 2026, requiring stringent inventory management.\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eFacility Lease\u003c\/td\u003e\n\u003ctd\u003eFixed Overhead\u003c\/td\u003e\n\u003ctd\u003eThe fixed facility lease expense is $12,000 per month for the clinic space.\u003c\/td\u003e\n\u003ctd\u003e$12,000\u003c\/td\u003e\n\u003ctd\u003e$12,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eMalpractice Insurance\u003c\/td\u003e\n\u003ctd\u003eFixed Overhead\u003c\/td\u003e\n\u003ctd\u003eMaintaining coverage requires a fixed monthly premium of $6,500, a critical risk management expense.\u003c\/td\u003e\n\u003ctd\u003e$6,500\u003c\/td\u003e\n\u003ctd\u003e$6,500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eConsumables\/Supplies\u003c\/td\u003e\n\u003ctd\u003eVariable COGS\u003c\/td\u003e\n\u003ctd\u003eThese variable costs, including syringes and testing materials, are estimated at 45% of revenue in 2026.\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003ePatient Marketing\u003c\/td\u003e\n\u003ctd\u003eSales \u0026amp; Marketing\u003c\/td\u003e\n\u003ctd\u003eInitial patient acquisition costs are budgeted at 50% of revenue in 2026, expected to decrease with referrals.\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eEHR\/IT Costs\u003c\/td\u003e\n\u003ctd\u003eFixed Overhead\u003c\/td\u003e\n\u003ctd\u003eThe monthly fixed cost for Electronic Health Record (EHR) software and IT maintenance is $2,200.\u003c\/td\u003e\n\u003ctd\u003e$2,200\u003c\/td\u003e\n\u003ctd\u003e$2,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003eTotal\u003c\/td\u003e\n\u003ctd\u003eAll Operating Expenses\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e$72,367\u003c\/td\u003e\n\u003ctd\u003e$72,367\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the total required operating budget for the first 12 months of the Rheumatoid Arthritis Treatment Clinic?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe total operating budget required to cover the first 12 months of the Rheumatoid Arthritis Treatment Clinic, assuming a ramp-up to \u003cstrong\u003e214 patient visits per month\u003c\/strong\u003e to cover fixed costs, is roughly \u003cstrong\u003e$287,700\u003c\/strong\u003e in initial cash burn before reaching break-even. If you are planning this out, understanding the foundational steps is key; you can review \u003ca href=\"\/blogs\/how-to-open\/rheumatoid-arthritis-clinic\"\u003eHow To Launch Rheumatoid Arthritis Treatment Clinic Business?\u003c\/a\u003e for the setup roadmap. Honestly, the first year is about covering that high fixed base while scaling volume.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Overhead Burn\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFixed overhead, including rent and admin payroll, hits \u003cstrong\u003e$75,000 per month\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAdd another \u003cstrong\u003e$5,000\u003c\/strong\u003e monthly for initial marketing spend during the ramp-up phase.\u003c\/li\u003e\n\u003cli\u003eThis means you need \u003cstrong\u003e$80,000\u003c\/strong\u003e in monthly cash flow just to keep the doors open.\u003c\/li\u003e\n\u003cli\u003eIf you only see \u003cstrong\u003e150 visits\u003c\/strong\u003e monthly, your operating deficit is about \u003cstrong\u003e$24,000\u003c\/strong\u003e a month.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVariable Costs \u0026amp; Break-Even\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eVariable costs (drugs, supplies, billing fees) total about \u003cstrong\u003e17%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003cli\u003eWith an average revenue per visit of \u003cstrong\u003e$450\u003c\/strong\u003e, variable costs are \u003cstrong\u003e$76.50\u003c\/strong\u003e per patient.\u003c\/li\u003e\n\u003cli\u003eYou need \u003cstrong\u003e214 patient visits\u003c\/strong\u003e monthly to cover the \u003cstrong\u003e$80,000\u003c\/strong\u003e fixed costs.\u003c\/li\u003e\n\u003cli\u003eIf you hit \u003cstrong\u003e214 visits\u003c\/strong\u003e, your monthly revenue is \u003cstrong\u003e$96,300\u003c\/strong\u003e, defintely covering the base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhich single recurring cost category will consume the largest percentage of revenue in Year 1?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe largest recurring cost for the Rheumatoid Arthritis Treatment Clinic in Year 1 will almost certainly be specialty drug inventory, consuming an estimated \u003cstrong\u003e85% of revenue\u003c\/strong\u003e, so understanding how to manage this expense is crucial, as detailed in this guide on \u003ca href=\"\/blogs\/profitability\/rheumatoid-arthritis-clinic\"\u003eHow Increase Profits Rheumatoid Arthritis Treatment Clinic?\u003c\/a\u003e. Focus optimization efforts immediately on procurement efficiency and payer reimbursement capture to manage this massive variable expense.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInventory Cost Control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate \u003cstrong\u003e30-day payment terms\u003c\/strong\u003e with primary drug distributors.\u003c\/li\u003e\n\u003cli\u003eImplement just-in-time stocking for high-cost, low-turnover biologics.\u003c\/li\u003e\n\u003cli\u003eTrack drug expiration closely; aim for less than \u003cstrong\u003e1% waste\u003c\/strong\u003e monthly.\u003c\/li\u003e\n\u003cli\u003eEnsure billing captures the full cost of goods sold (COGS) immediately.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Cost Levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStagger onboarding of specialized physical therapists defintely.\u003c\/li\u003e\n\u003cli\u003eLease negotiation: Secure a \u003cstrong\u003e12-month rent abatement\u003c\/strong\u003e period.\u003c\/li\u003e\n\u003cli\u003eTie fixed payroll growth to patient volume milestones, not just schedule.\u003c\/li\u003e\n\u003cli\u003eIf facility lease is \u003cstrong\u003e$15,000\/month\u003c\/strong\u003e, it requires \u003cstrong\u003e$17,647\u003c\/strong\u003e in monthly revenue just to cover it (15,000 \/ 0.85).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow much working capital (cash buffer) is necessary to cover costs until the clinic reaches stable profitability?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Rheumatoid Arthritis Treatment Clinic needs a minimum cash buffer of \u003cstrong\u003e$846,000\u003c\/strong\u003e by February 2026 to cover operating costs before achieving stable profitability, meaning funding sources must be secured now; understanding this gap is key to operational runway, but you should also review strategies on \u003ca href=\"\/blogs\/profitability\/rheumatoid-arthritis-clinic\"\u003eHow Increase Profits Rheumatoid Arthritis Treatment Clinic?\u003c\/a\u003e.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCash Requirement Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThis \u003cstrong\u003e$846,000\u003c\/strong\u003e figure is the cumulative negative cash flow until stability.\u003c\/li\u003e\n\u003cli\u003eIt assumes the current cost structure and patient onboarding pace hold.\u003c\/li\u003e\n\u003cli\u003eTrack actual monthly burn against this projection defintely.\u003c\/li\u003e\n\u003cli\u003eIf patient volume is \u003cstrong\u003e15%\u003c\/strong\u003e lower than planned, the required buffer increases.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFunding Action Plan\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSecure commitments covering the \u003cstrong\u003e$846k\u003c\/strong\u003e need plus a \u003cstrong\u003e20%\u003c\/strong\u003e contingency buffer.\u003c\/li\u003e\n\u003cli\u003eIf stability hits in 24 months, that's about \u003cstrong\u003e$35,250\u003c\/strong\u003e in capital needed monthly.\u003c\/li\u003e\n\u003cli\u003ePrioritize equity or venture debt; operating cash flow won't cover this gap early.\u003c\/li\u003e\n\u003cli\u003eModel how cutting fixed overhead by \u003cstrong\u003e$5,000\u003c\/strong\u003e monthly shortens the funding timeline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eIf patient volume and revenue fall 20% below projections, how will the clinic cover its fixed monthly expenses?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eIf revenue for the Rheumatoid Arthritis Treatment Clinic drops 20% below projections, immediate coverage depends on aggressively reducing or deferring fixed costs, which total at least \u003cstrong\u003e$18,500\u003c\/strong\u003e monthly based on standard startup estimates, a critical step detailed further in analyses like \u003ca href=\"\/blogs\/startup-costs\/rheumatoid-arthritis-clinic\"\u003eHow Much To Start Rheumatoid Arthritis Treatment Clinic Business?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePinpoint High-Impact Fixed Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe primary fixed burden is the \u003cstrong\u003e$12,000\u003c\/strong\u003e monthly lease payment for clinic space.\u003c\/li\u003e\n\u003cli\u003eProfessional liability and general insurance costs run about \u003cstrong\u003e$6,500\u003c\/strong\u003e monthly.\u003c\/li\u003e\n\u003cli\u003eThese two items alone account for \u003cstrong\u003e$18,500\u003c\/strong\u003e in required monthly cash flow.\u003c\/li\u003e\n\u003cli\u003eLook at non-clinical software subscriptions as secondary targets for immediate cuts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStrategy for Deferring Overhead\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eApproach the landlord immediately to request a \u003cstrong\u003ethree-month rent abatement\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAsk the insurer to shift to a quarterly payment schedule to free up cash now.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises, so focus on immediate cash preservation.\u003c\/li\u003e\n\u003cli\u003eBe prepared to offer a shorter lease extension in exchange for immediate concessions; defintely explore this.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eThe estimated initial monthly running cost for a Rheumatoid Arthritis Treatment Clinic falls within the range of $115,000 to $130,000, heavily influenced by payroll and drug inventory.\u003c\/li\u003e\n\n\u003cli\u003eSpecialty biologic drug inventory is the largest single cost driver, projected to consume 85% of revenue, necessitating stringent inventory and supplier management.\u003c\/li\u003e\n\n\u003cli\u003eA significant minimum cash buffer of $846,000 is required to cover early operational shortfalls until the clinic reaches stable profitability.\u003c\/li\u003e\n\n\u003cli\u003eDespite high overheads, the financial model anticipates the clinic will achieve breakeven status in just one month, projecting $2.318 million in Year 1 revenue.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 1\n: \u003cspan style=\"color: #126CFF;\"\u003eFixed Administrative Payroll\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAdmin Payroll Base\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour core leadership and admin salaries are locked in at about \u003cstrong\u003e$51,667 monthly\u003c\/strong\u003e in 2026. This figure covers key roles like the Lead Rheumatologist and Clinic Director but skips performance-based clinical pay. This fixed overhead sets your initial operational floor.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStaffing Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$51,667\u003c\/strong\u003e monthly payroll covers essential, non-clinical overhead required to run the clinic, including the Lead Rheumatologist, Clinic Director, and Billing Manager salaries. This is a fixed commitment separate from the 85% drug inventory cost. You must budget this amount monthly, starting before the first patient visit.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSalaries for \u003cstrong\u003e3 key roles\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFixed monthly commitment.\u003c\/li\u003e\n\u003cli\u003eExcludes variable clinical pay.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eControlling Fixed Pay\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSince this is fixed payroll, cutting it fast is hard without impacting compliance or patient flow. Avoid hiring non-essential administrative staff early on; use part-time or outsourced billing until patient volume justifies a full-time Billing Manager. If onboarding takes 14+ days, churn risk rises defintely.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDelay hiring non-essential roles.\u003c\/li\u003e\n\u003cli\u003eUse outsourced billing initially.\u003c\/li\u003e\n\u003cli\u003eEnsure quick onboarding processes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOverhead Context\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eRemember, this \u003cstrong\u003e$51.7k\u003c\/strong\u003e is just the management layer. It sits on top of huge variable expenses like the \u003cstrong\u003e85%\u003c\/strong\u003e Specialty Biologic Drug Inventory cost and the \u003cstrong\u003e$12,000\u003c\/strong\u003e facility lease. Your contribution margin must cover this base salary load quickly.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 2\n: \u003cspan style=\"color: #126CFF;\"\u003eSpecialty Biologic Drug Inventory\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBiologics Cost Dominance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSpecialty biologic drugs are your primary expense, eating up \u003cstrong\u003e85% of revenue\u003c\/strong\u003e by 2026. This massive Cost of Goods Sold (COGS) dictates your entire profitability structure. You must control drug stock levels tightly, because any inefficiency here directly erodes your margin.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInputs for Drug Inventory\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis cost covers the high-price biologic medications administered to rheumatoid arthritis patients. Estimate this by tracking drug acquisition cost per unit against projected patient treatment volume. If revenue hits $1M, this single line item consumes $850,000. It dwarfs other variable costs like consumables, which are only \u003cstrong\u003e45% of revenue\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack acquisition cost per vial\u003c\/li\u003e\n\u003cli\u003eProject patient treatment frequency\u003c\/li\u003e\n\u003cli\u003eMonitor expiration dates closely\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging High Inventory Risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eManaging 85% COGS means negotiating better payment terms and minimizing waste. Seek \u003cstrong\u003enet-30 or net-60 payment windows\u003c\/strong\u003e from suppliers to ease working capital strain. Avoid holding excess stock, as these are high-value, specialized assets. Poor inventory tracking will kill your cash flow defintely.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePush for consignment agreements\u003c\/li\u003e\n\u003cli\u003eStandardize administration protocols\u003c\/li\u003e\n\u003cli\u003eReview supplier discounts regularly\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eSupplier Terms Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour gross margin hinges entirely on supplier agreements and avoiding expired stock write-offs. If you can negotiate supply costs down even 5 percentage points, that directly translates into \u003cstrong\u003e$50,000 saved\u003c\/strong\u003e per $1M revenue run rate. This is where operational finance focus must live.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 3\n: \u003cspan style=\"color: #126CFF;\"\u003eMedical Facility Lease\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLocking Down Clinic Space\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe clinic space lease locks in a \u003cstrong\u003e$12,000\u003c\/strong\u003e monthly fixed overhead before seeing a single patient. This non-negotiable cost hits immediately, regardless of revenue performance in the early months. You've got to ensure working capital covers this expense for at least six months, defintely, before volume ramps up.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eEstimating Fixed Space Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$12,000\u003c\/strong\u003e covers the physical footprint needed for integrated RA care, including specialized treatment and diagnostic areas. It's a pure fixed expense, unlike inventory (which is \u003cstrong\u003e85%\u003c\/strong\u003e of revenue) or supplies (\u003cstrong\u003e45%\u003c\/strong\u003e of revenue). Finalizing this lease amount is critical before budgeting the \u003cstrong\u003e$51,667\u003c\/strong\u003e fixed payroll.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eLease is pure fixed overhead.\u003c\/li\u003e\n\u003cli\u003eCovers physical clinic footprint.\u003c\/li\u003e\n\u003cli\u003eMust be paid monthly, no exceptions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Lease Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSince the lease is fixed, optimization means negotiating favorable tenant improvement allowances upfront to shift build-out costs. Avoid signing for space much larger than immediately required; excess square footage inflates the fixed cost basis. If patient onboarding takes 14+ days, churn risk rises before this fixed cost is covered.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate tenant improvement funds.\u003c\/li\u003e\n\u003cli\u003eAvoid oversized initial footprints.\u003c\/li\u003e\n\u003cli\u003eEnsure quick patient activation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLease Impact on Break-Even\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCompared to the \u003cstrong\u003e$6,500\u003c\/strong\u003e malpractice premium and \u003cstrong\u003e$2,200\u003c\/strong\u003e IT costs, the lease is the largest non-payroll fixed burden. You must generate enough fee-for-service revenue to cover this \u003cstrong\u003e$12k\u003c\/strong\u003e plus payroll before variable costs like biologic drugs start consuming cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 4\n: \u003cspan style=\"color: #126CFF;\"\u003eMalpractice Insurance Premium\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Insurance Cost\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must budget for a fixed \u003cstrong\u003e$6,500 monthly premium\u003c\/strong\u003e for malpractice insurance. This isn't optional; it's a baseline regulatory requirement to operate legally and protect the clinic from liability claims related to patient care. It hits the budget every single month, regardless of patient volume.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCoverage Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$6,500 premium\u003c\/strong\u003e covers professional liability protection for all practitioners treating rheumatoid arthritis patients. It's a fixed overhead, unlike drug inventory (85% of revenue) or lab supplies (45% of revenue). You need this quote locked in before seeing the first patient.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFixed cost: $6,500 monthly.\u003c\/li\u003e\n\u003cli\u003eCovers regulatory risk.\u003c\/li\u003e\n\u003cli\u003eEssential for operations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Premiums\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou can't cut this cost to zero, but you can shop carriers annually. Compare quotes based on your projected patient volume and the complexity of biologic treatments used. Don't skimp on limits just to save a few hundred dollars; that's bad risk management.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShop carriers yearly.\u003c\/li\u003e\n\u003cli\u003eAdjust limits carefully.\u003c\/li\u003e\n\u003cli\u003eAvoid coverage gaps.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Cost Stacking\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis $6,500 premium is a fixed drain, just like the $12,000 lease and the $51,667 payroll. You defintely need to factor this into your contribution margin analysis early on. It's a necessary expense for operating in the medical field.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 5\n: \u003cspan style=\"color: #126CFF;\"\u003eMedical Consumables and Lab Supplies\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eConsumables Cost Hit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eMedical consumables and lab supplies represent a major variable cost for your clinic. In 2026, expect these items-like syringes and testing kits-to consume \u003cstrong\u003e45% of total revenue\u003c\/strong\u003e. This percentage should ease downward slightly as you scale volume.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCost Inputs Needed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis 45% covers direct patient use items. To budget accurately, you need your projected \u003cstrong\u003ePatient Volume\u003c\/strong\u003e multiplied by the average cost per procedure kit. If 2026 revenue hits $5 million, this line item is $2.25 million. Defintely track usage per rheumatologist.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSyringes and needles\u003c\/li\u003e\n\u003cli\u003eDiagnostic testing kits\u003c\/li\u003e\n\u003cli\u003eOn-site lab reagents\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCutting Supply Drag\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eManage this 45% by negotiating bulk purchasing agreements with two primary medical distributors. Standardize testing protocols to reduce unnecessary reagent waste. Avoid overstocking expensive biologic components, which ties up working capital unnecessarily.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOperational Focus\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eBecause this cost is tied directly to service delivery, improving clinical efficiency directly lowers its percentage share. Focus on optimizing the time between patient arrival and supply usage to maximize throughput without increasing inventory holding costs.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 6\n: \u003cspan style=\"color: #126CFF;\"\u003ePatient Marketing and Digital Ads\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAcquisition Target\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour initial patient marketing budget for 2026 is set high at \u003cstrong\u003e50% of revenue\u003c\/strong\u003e. This reflects the cost of building a new specialty clinic brand from scratch. The financial model expects this percentage to drop significantly as organic patient referrals start kicking in later.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMarketing Spend Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e50%\u003c\/strong\u003e marketing budget is a direct variable cost tied to top-line revenue for 2026. It funds digital ads necessary to find new rheumatoid arthritis patients. Compare this to the \u003cstrong\u003e85%\u003c\/strong\u003e projected for specialty biologic drugs, showing marketing is the second biggest expense category initially.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLowering Acquisition Drag\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo reduce this heavy initial spend, focus intensely on patient satisfaction scores right away. A high-quality experience drives word-of-mouth referrals, which are essentially free marketing. If onboarding takes 14+ days, churn risk rises, hurting the referral pipeline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eReferral Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eHitting your referral goals directly improves gross margin because every referred patient bypasses the \u003cstrong\u003e50%\u003c\/strong\u003e acquisition cost. This shift is the primary lever for moving from break-even pressure to genuine profitability in years two and three.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 7\n: \u003cspan style=\"color: #126CFF;\"\u003eEHR and IT Infrastructure\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eIT Infrastructure Baseline\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour rheumatoid arthritis clinic faces a mandatory fixed operating expense of \u003cstrong\u003e$2,200 per month\u003c\/strong\u003e for Electronic Health Record (EHR) software and IT upkeep. This cost is foundational because without a functioning EHR, you cannot securely manage patient records or successfully submit claims for billing and regulatory compliance.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCost Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$2,200\u003c\/strong\u003e is derived directly from the contract price for the EHR platform and ongoing IT support services needed to keep systems secure. It is a fixed overhead component, sitting below your \u003cstrong\u003e$12,000\u003c\/strong\u003e facility lease but above variable supply costs. You need the signed vendor quote to lock this number in. Honestly, this cost is definately non-negotiable.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCovers software licensing fees.\u003c\/li\u003e\n\u003cli\u003eIncludes essential IT maintenance.\u003c\/li\u003e\n\u003cli\u003eFixed at \u003cstrong\u003e$2,200\u003c\/strong\u003e monthly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Tech Overhead\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDo not overbuy features you won't use in the first year. Negotiate multi-year contracts only after you have proven your patient volume can support the fixed cost, or you risk getting locked in too early. If onboarding takes longer than expected, ensure the vendor credit covers downtime.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eConfirm setup fees are separate costs.\u003c\/li\u003e\n\u003cli\u003eAudit required user licenses semi-annually.\u003c\/li\u003e\n\u003cli\u003eDemand service level agreements (SLAs).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRisk Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your EHR system goes down, your ability to bill patients stops immediately. This \u003cstrong\u003e$2,200\u003c\/strong\u003e expense is a direct insurance policy for revenue continuity and HIPAA compliance; cutting it means risking much larger fines or lost collections down the road.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304462393587,"sku":"rheumatoid-arthritis-clinic-running-expenses","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/rheumatoid-arthritis-clinic-running-expenses.webp?v=1782691181","url":"https:\/\/financialmodelslab.com\/products\/rheumatoid-arthritis-clinic-running-expenses","provider":"Financial Models Lab","version":"1.0","type":"link"}